Literature DB >> 31437721

The neuritic plaque in Alzheimer's disease: perivascular degeneration of neuronal processes.

Gurpreet Kaur Hansra1, Glib Popov1, Patricia O Banaczek1, Monica Vogiatzis1, Thuvarahan Jegathees1, Claire S Goldbury2, Karen M Cullen3.   

Abstract

Cerebrovascular pathology is common in aging and Alzheimer's disease (AD). The microvasculature is particularly vulnerable, with capillary-level microhemorrhages coinciding with amyloid beta deposits in senile plaques. In the current analysis, we assessed the relationship between cerebral microvessels and the neuritic component of the plaque in cortical and hippocampal 50- to 200-μm sections from 11 AD, 3 Down syndrome, and 7 nondemented cases in neuritic disease stages 0-VI. We report that 77%-97% of neuritic plaques are perivascular, independently of disease stage or dementia diagnosis. Within neuritic plaques, dystrophic hyperphosphorylated tau-positive neurites appear as clusters of punctate, bulbous, and thread-like structures focused around capillaries and colocalize with iron deposits characteristic of microhemorrhage. Microvessels within the neuritic plaque are narrowed by 1.0 ± 1.0 μm-4.4 ± 2.0 μm, a difference of 16%-65% compared to blood vessel segments with diameters 7.9 ± 2.0-6.4 ± 0.8 μm (p < 0.01) outside the plaque domain. The reduced capacity of microvessels within plaques, frequently below patency, likely compromises normal microlocal cerebrovascular perfusion. These data link the neuritic and amyloid beta components of the plaque directly to microvascular degeneration. Strategies focused on cerebrovascular antecedents to neuritic dystrophy in AD have immediate potential for prevention, detection, and therapeutic intervention. Crown
Copyright © 2019. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Cerebrovasculature; Dystrophic neurites; Microhemorrhage; Neuritic plaque; tau

Mesh:

Year:  2019        PMID: 31437721     DOI: 10.1016/j.neurobiolaging.2019.06.009

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  10 in total

1.  Sexual differences in mitochondrial and related proteins in rat cerebral microvessels: A proteomic approach.

Authors:  Sinisa Cikic; Partha K Chandra; Jarrod C Harman; Ibolya Rutkai; Prasad Vg Katakam; Jessie J Guidry; Jeffrey M Gidday; David W Busija
Journal:  J Cereb Blood Flow Metab       Date:  2020-04-02       Impact factor: 6.200

2.  Non-productive angiogenesis disassembles Aß plaque-associated blood vessels.

Authors:  Maria I Alvarez-Vergara; Alicia E Rosales-Nieves; Rosana March-Diaz; Guiomar Rodriguez-Perinan; Nieves Lara-Ureña; Clara Ortega-de San Luis; Manuel A Sanchez-Garcia; Miguel Martin-Bornez; Pedro Gómez-Gálvez; Pablo Vicente-Munuera; Beatriz Fernandez-Gomez; Miguel A Marchena; Andrea S Bullones-Bolanos; Jose C Davila; Rocio Gonzalez-Martinez; Jose L Trillo-Contreras; Ana C Sanchez-Hidalgo; Raquel Del Toro; Francisco G Scholl; Eloisa Herrera; Martin Trepel; Jakob Körbelin; Luis M Escudero; Javier Villadiego; Miriam Echevarria; Fernando de Castro; Antonia Gutierrez; Alberto Rabano; Javier Vitorica; Alberto Pascual
Journal:  Nat Commun       Date:  2021-05-25       Impact factor: 14.919

3.  Tau Protein Phosphorylated at Threonine-231 is Expressed Abundantly in the Cerebellum in Prion Encephalopathies.

Authors:  Vıctor Manuel Gómez-López; Amparo Viramontes-Pintos; Miguel Ángel Ontiveros-Torres; Linda Garcés-Ramírez; Fidel de la Cruz; Ignacio Villanueva-Fierro; Marely Bravo-Muñoz; Charles R Harrington; Sandra Martínez-Robles; Petra Yescas; Parménides Guadarrama-Ortíz; Mario Hernandes-Alejandro; Francisco Montiel-Sosa; Mar Pacheco-Herrero; José Luna-Muñoz
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

4.  miR‑199a decreases Neuritin expression involved in the development of Alzheimer's disease in APP/PS1 mice.

Authors:  Dandan Song; Guoxiang Li; Yu Hong; Pan Zhang; Jingling Zhu; Lei Yang; Jin Huang
Journal:  Int J Mol Med       Date:  2020-05-12       Impact factor: 4.101

Review 5.  Tauopathies: new perspectives and challenges.

Authors:  Yi Zhang; Kai-Min Wu; Liu Yang; Qiang Dong; Jin-Tai Yu
Journal:  Mol Neurodegener       Date:  2022-04-07       Impact factor: 14.195

6.  Aβ (Amyloid Beta) and Tau Tangle Pathology Modifies the Association Between Small Vessel Disease and Cortical Microinfarcts.

Authors:  A Kapasi; S E Leurgans; Z Arvanitakis; L L Barnes; D A Bennett; J A Schneider
Journal:  Stroke       Date:  2021-02-11       Impact factor: 7.914

Review 7.  Iron and Ferroptosis as Therapeutic Targets in Alzheimer's Disease.

Authors:  Andrew Gleason; Ashley I Bush
Journal:  Neurotherapeutics       Date:  2020-10-27       Impact factor: 7.620

Review 8.  Cerebral blood flow decrease as an early pathological mechanism in Alzheimer's disease.

Authors:  Nils Korte; Ross Nortley; David Attwell
Journal:  Acta Neuropathol       Date:  2020-08-31       Impact factor: 17.088

Review 9.  An Analysis of the Neurological and Molecular Alterations Underlying the Pathogenesis of Alzheimer's Disease.

Authors:  Chantal Vidal; Li Zhang
Journal:  Cells       Date:  2021-03-04       Impact factor: 6.600

Review 10.  Visualization of neurofibrillary tangle maturity in Alzheimer's disease: A clinicopathologic perspective for biomarker research.

Authors:  Christina M Moloney; Val J Lowe; Melissa E Murray
Journal:  Alzheimers Dement       Date:  2021-04-02       Impact factor: 21.566

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.